Cryoservice manager runs the extra mile for Cancer Research

David Bryant completes 145-mile Grand Union Canal Run from Birmingham to London

The 145-mile Grand Union Canal Run is generally acknowledged as Britain’s longest continual race. Starting in Broad Street, Birmingham and finishing in Little Italy, London, competitors have to complete the race in 45 hours.

David Bryant, Cryoservice's business manager for science and industry, took 39 hours 15 minutes to complete the distance, running without sleep or a reasonable break.

‘The race is extremely challenging with only 40% of the starting line up normally finishing, so a hard training regime was required even to be in with a chance of reaching London,’ he said.

‘What kept me going was the knowledge that so many people had sponsored me and that the money raised would be going to a good cause.’

Bryant raised £3,350 for Cancer Research and came 16th.

Cryoservice, a supplier of specialist gases for science, leisure and industry, based in Worcester, UK, is a long-term business partner of Cancer Research UK and was recently short-listed for Supplier of the Year award, in recognition of its commitment and support of the organisation.

You may also like

Manufacturing

Pharmaceutical labelling in focus at Interpack 2026

Well prepared for new requirements. The upcoming reform of EU pharmaceutical legislation is expected to bring stricter requirements for traceability and labelling. The new 152E HC wrap-around labelling machine, developed specifically for contract packers, covers a wide product range with minimal change parts. Also on display: specialised labelling machines for automated product handling of small batches and high-speed labelling applications.
Cell & Gene Therapy

First CAR-T therapy for solid tumours set to launch in China

Claudin18.2-targeting CAR-T therapy satri-cel (CT041) is expected to become the first treatment of its kind for solid tumours, offering a new option for patients with advanced gastrointestinal cancers
Manufacturing

Virica Biotech and FUJIFILM Biosciences collaborate to boost AAV vector yields in HEK293 manufacturing system

Virica Biotech has announced a collaboration with FUJIFILM Biosciences to co-develop an off-the-shelf enhancer-media solution combining Virica's VSE technology with FUJIFILM's BalanCD HEK293 system, targeting improved AAV productivity and process robustness for gene therapy manufacturers
Marketing

Ofichem consolidates six brands into single integrated CDMO and pharmaceutical supplier identity

Dutch family-owned pharmaceutical company Ofichem has unified its six business units — spanning API, drug substance, drug product and distribution — under a single trading name
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Accelerating the development of bispecific antibodies

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market
Analysis

Conjugation chemistry key to unlocking next-generation oligonucleotide therapies, says Bachem

As demand for oligonucleotide therapeutics accelerates, Bachem's Director of Oligonucleotide Production explains how conjugation chemistry is helping CDMOs overcome delivery challenges
Manufacturing

UK pharmaceutical manufacturers struggling to meet F-Gas compliance amid ageing cooling infrastructure

A new Aggreko report reveals that nearly all UK pharmaceutical manufacturers are facing barriers to upgrading cooling systems ahead of the accelerating F-Gas phase-down timeline
Subscribe now